Abbott Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	44,328	41,950	40,109	43,653	43,075
Revenue Growth (YoY)	5.67%	4.59%	-8.12%	1.34%	24.46%
Cost of Revenue	19,319	18,706	17,975	19,142	18,537
Gross Profit	25,009	23,244	22,134	24,511	24,538
Selling, General & Admin	12,332	11,697	10,949	11,248	11,324
Depreciation & Amortization Expenses	1,682	1,878	1,966	2,013	2,047
Research & Development	2,942	2,844	2,741	2,888	2,742
Total Operating Expenses	16,956	16,419	15,656	16,149	16,113
Operating Income	8,053	6,825	6,478	8,362	8,425
Interest Income	308	344	385	183	43
Interest Expense	-493	-559	-637	-558	-533
Other Non-Operating Income (Expense)	598	403	438	319	276
Total Non-Operating Income (Expense)	413	188	186	-56	-214
Pretax Income	8,466	7,013	6,664	8,306	8,211
Provision for Income Taxes	1,942	-6,389	941	1,373	1,140
Net Income	6,524	13,402	5,723	6,933	7,071
Net Income to Common	6,524	13,402	5,723	6,933	7,071
Net Income Growth	-51.32%	134.18%	-17.45%	-1.95%	57.31%
Shares Outstanding (Basic)	1,741	1,740	1,740	1,753	1,775
Shares Outstanding (Diluted)	1,748	1,748	1,749	1,764	1,789
Shares Change (YoY)	-	-0.06%	-0.85%	-1.40%	0.17%
EPS (Basic)	3.73	7.67	3.28	3.94	3.97
EPS (Diluted)	3.72	7.64	3.26	3.91	3.94
EPS Growth	-51.31%	134.36%	-16.62%	-0.76%	57.60%
Free Cash Flow	7,395	6,351	5,059	7,804	8,648
Free Cash Flow Growth	16.44%	25.54%	-35.17%	-9.76%	51.08%
Free Cash Flow Per Share	4.23	3.63	2.89	4.42	4.83
Dividends Per Share	2.400	2.240	2.080	1.920	1.820
Dividend Growth	7.14%	7.69%	8.33%	5.50%	18.95%
Gross Margin	56.42%	55.41%	55.18%	56.15%	56.97%
Operating Margin	18.17%	16.27%	16.15%	19.16%	19.56%
Profit Margin	14.72%	31.95%	14.27%	15.88%	16.42%
FCF Margin	16.68%	15.14%	12.61%	17.88%	20.08%
EBITDA	11,169	10,043	9,721	11,629	11,963
EBITDA Margin	25.20%	23.94%	24.24%	26.64%	27.77%
EBIT	8,053	6,825	6,478	8,362	8,425
EBIT Margin	18.17%	16.27%	16.15%	19.16%	19.56%
Effective Tax Rate	22.94%	-91.10%	14.12%	16.53%	13.88%

Updated Jan 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q